Over the past 12 months, 7 insiders at Cullinan Therapeutics, Inc. filed 34 open-market SEC Form 4 transactions on CGEM: 8 purchases worth $13.3M and 26 sales worth $1.7M. Insiders have been net sellers over this period. The most recent filing was on Jul 6, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 6, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 8.0K | $17.82 | $143K |
| May 5, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 7.8K | $15.58 | $114K |
| Mar 5, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 8.0K | $15.68 | $125K |
| Feb 25, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 1.8K | $14.14 | $25K |
| Feb 24, 26 | Nadim AhmedPresident and CEO | SELL | 13.5K | $14.47 | $196K |
| Feb 24, 26 | Jeffrey Alan JonesChief Medical Officer | SELL | 4.6K | $14.47 | $66K |
| Feb 24, 26 | Jacquelyn L SumerChief Legal Officer | SELL | 3.6K | $14.47 | $52K |
| Feb 24, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 3.6K | $14.47 | $52K |
| Feb 23, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 1.8K | $13.99 | $25K |
| Feb 20, 26 | Nadim AhmedPresident and CEO | SELL | 16.4K | $13.62 | $223K |
| Feb 20, 26 | Mary Kay FentonChief Financial Officer | SELL | 4.4K | $13.62 | $60K |
| Feb 20, 26 | Jeffrey Alan JonesChief Medical Officer | SELL | 5.0K | $13.62 | $68K |
| Feb 20, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 8.0K | $14.30 | $114K |
| Feb 20, 26 | Jacquelyn L SumerChief Legal Officer | SELL | 3.7K | $13.62 | $51K |
| Feb 12, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 416 | $12.03 | $5K |
| Jan 22, 26 | Jennifer MichaelsonChief Scientific Officer | SELL | 4.0K | $12.30 | $49K |
| Dec 23, 25 | Nadim AhmedPresident and CEO | SELL | 9.9K | $10.01 | $99K |
| Dec 19, 25 | Jennifer MichaelsonChief Scientific Officer | SELL | 1.3K | $10.01 | $13K |
| Dec 18, 25 | Jeffrey Alan JonesChief Medical Officer | SELL | 4.6K | $9.67 | $45K |
| Dec 18, 25 | Jennifer MichaelsonChief Scientific Officer | SELL | 2.9K | $9.67 | $28K |
| Dec 18, 25 | Jacquelyn L SumerChief Legal Officer | SELL | 3.5K | $9.67 | $34K |
| Dec 15, 25 | Jennifer MichaelsonChief Scientific Officer | SELL | 995 | $11.90 | $12K |
| Dec 12, 25 | Jennifer MichaelsonChief Scientific Officer | SELL | 2.1K | $12.38 | $27K |
| Nov 24, 25 | Jennifer MichaelsonChief Scientific Officer | SELL | 4.0K | $12.30 | $49K |
| Oct 28, 25 | Weston NicholsTenPercentOwner | BUY | 165.7K | $8.40 | $1.4M |
| Oct 17, 25 | Lynx1 Capital Management LpTenPercentOwner | BUY | 32.2K | $7.84 | $253K |
| Oct 16, 25 | Lynx1 Capital Management LpTenPercentOwner | BUY | 150.0K | $8.86 | $1.3M |
| Oct 15, 25 | Lynx1 Capital Management LpTenPercentOwner | BUY | 51.5K | $7.94 | $409K |
| Oct 14, 25 | Lynx1 Capital Management LpTenPercentOwner | BUY | 15.0K | $7.59 | $114K |
| Oct 10, 25 | Lynx1 Capital Management LpTenPercentOwner | BUY | 277.3K | $7.36 | $2.0M |
| Oct 9, 25 | Lynx1 Capital Management LpTenPercentOwner | BUY | 626.0K | $6.70 | $4.2M |
| Oct 8, 25 | Lynx1 Capital Management LpTenPercentOwner | BUY | 556.3K | $6.46 | $3.6M |
| Feb 25, 25 | Nadim AhmedPresident and CEO | SELL | 12.5K | $8.53 | $107K |
| Feb 25, 25 | Jeffrey Alan JonesChief Medical Officer | SELL | 4.9K | $8.53 | $42K |
| Feb 25, 25 | Jennifer MichaelsonChief Scientific Officer | SELL | 3.8K | $8.53 | $32K |
| Feb 25, 25 | Jacquelyn L SumerChief Legal Officer | SELL | 3.8K | $8.53 | $32K |
| Jan 6, 25 | Jennifer MichaelsonChief Scientific Officer | SELL | 4.0K | $12.51 | $50K |
| Dec 24, 24 | Nadim AhmedPresident and CEO | SELL | 8.4K | $11.87 | $100K |
| Dec 18, 24 | Jeffrey Alan JonesChief Medical Officer | SELL | 4.6K | $11.41 | $53K |
| Dec 18, 24 | Jennifer MichaelsonChief Scientific Officer | SELL | 4.7K | $11.41 | $54K |
| Dec 18, 24 | Jacquelyn L SumerChief Legal Officer | SELL | 3.5K | $11.41 | $40K |
| Dec 12, 24 | Jennifer MichaelsonChief Scientific Officer | SELL | 3.5K | $12.52 | $44K |
| Nov 5, 24 | Jennifer MichaelsonChief Scientific Officer | SELL | 8.0K | $15.64 | $125K |
| Sep 5, 24 | Jennifer MichaelsonChief Scientific Officer | SELL | 8.0K | $18.09 | $145K |
| Jul 5, 24 | Jennifer MichaelsonChief Scientific Officer | SELL | 8.0K | $16.33 | $131K |
| May 7, 24 | Jennifer MichaelsonChief Scientific Officer | SELL | 5.6K | $30.06 | $169K |
| May 6, 24 | Jennifer MichaelsonChief Scientific Officer | SELL | 37.7K | $28.54 | $1.0M |
| Feb 1, 24 | Corrine SavillChief Business Officer | SELL | 40.0K | $16.18 | $647K |
| Jan 29, 24 | Corrine SavillChief Business Officer | SELL | 40.0K | $14.09 | $564K |
| Jan 23, 24 | Corrine SavillChief Business Officer | SELL | 21.3K | $12.46 | $266K |
Over the past 12 months, insiders at Cullinan Therapeutics, Inc. filed 8 open-market purchases worth $13.3M and 26 sales worth $1.7M on CGEM, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 6, 26.
The largest recent open-market CGEM insider purchase in our data was $4.2M by Lynx1 Capital Management Lp, TenPercentOwner, filed on Oct 9, 25.
7 different insiders at Cullinan Therapeutics, Inc. filed open-market SEC Form 4 transactions on CGEM over the last 12 months.
InsiderTape plots every CGEM insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Cullinan Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →